Intrinsic Value of S&P & Nasdaq Contact Us

PepGen Inc. PEPG NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
56/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$12.50
+639.6%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

PepGen Inc. (PEPG) has a negative trailing P/E of -0.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -128.30%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+639.6%).
  • Trailing Earnings Yield -128.30% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $12.50 (+639.6% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 55/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
56/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — PEPG

Valuation Multiples
P/E (TTM)-0.8
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.47
P/S Ratio0.00
EV/EBITDA-0.8
Per Share Data
EPS (TTM)$-2.12
Book Value / Share$3.49
Revenue / Share$0.00
FCF / Share$-1.94
Yields & Fair Value
Earnings Yield-128.30%
Dividend Yield0.00%
Analyst Target$12.50 (+639.6%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -214.4 0.00 74.64 0.00 -
2020 -52.7 -0.07 10.18 0.00 -
2021 -10.6 -0.08 2.17 0.00 -
2022 -3.0 -0.01 1.16 0.00 -
2023 -2.1 0.08 1.49 0.00 -
2024 -1.3 0.10 1.01 0.00 -
2025 -3.1 0.12 1.86 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.06 $0.00 $-1.35M -
2020 $-0.08 $0.00 $-1.89M -
2021 $-1.22 $0.00 $-27.28M -
2022 $-4.42 $0.00 $-69.1M -
2023 $-3.30 $0.00 $-78.63M -
2024 $-2.85 $0.00 $-89.98M -
2025 $-2.12 $0.00 $-89.66M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.15 $-1.42 – $-0.95 $37.46M $37.46M – $37.46M 5
2027 $-1.13 $-1.71 – $-0.84 $4.61M $4.61M – $4.61M 5
2028 $-1.10 $-1.77 – $-0.73 $31.13M $31.13M – $31.13M 4
2029 $-0.83 $-0.83 – $-0.83 $28.87M $28.87M – $28.87M 2
2030 $-0.36 $-0.36 – $-0.36 $73.04M $73.04M – $73.04M 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message